Stock TARO TARO PHARMACEUTICAL INDUSTRIES LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Taro Pharmaceutical Industries Ltd.

Equities

TARO

IL0010827181

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-31 pm EDT 		5-day change 1st Jan Change
42.82 USD +0.33% Intraday chart for Taro Pharmaceutical Industries Ltd. +0.30% +2.49%
May. 23 Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical MT
May. 22 Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical
MT
Taro Shareholders Approve Merger with Sun Pharma
PR
Taro Shareholders Approve Merger with Sun Pharma
AQ
Taro Pharmaceutical Industries : Shareholders Approve Merger with Sun Pharma - Form 6-K
PU
Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call
Transcript : Taro Pharmaceutical Industries Ltd. - Shareholder/Analyst Call
Taro Pharmaceutical Industries : PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024 - Form 6-K
PU
Taro Pharmaceutical Industries Fiscal Q4 Earnings, Revenue Rise
MT
Taro: Fiscal Q4 Earnings Snapshot
AQ
Earnings Flash (TARO) TARO PHARMACEUTICAL INDUSTRIES Reports Q4 Revenue $164.9M, vs. Street Est of $156.1M
MT
Taro Provides Results for Year Ended March 31, 2024
BU
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Taro Pharmaceutical Industries Ltd. Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun Pharmaceutical Industries Limited.
PR
Taro to Release Full Year Results on May 20, 2024
BU
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote 'FOR' Taro Sun Pharma Merger
AQ
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger
BU
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TARO, HES, ANSS
PR
TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TARO
BU
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TARO Stock
  4. News Taro Pharmaceutical Industries Ltd.